Postoperative autologous peripheral blood mononuclear cell therapy in the rehabilitation of children with chronic hypertrophic rhinitis: a prospective comparative study

ORIGINAL RESEARCH

Cell and Organ Transplantology. 2026; 14(1):e2026141188.
DOI: 10.22494/cot.v14-1.188

Postoperative autologous peripheral blood mononuclear cell therapy in the rehabilitation of children with chronic hypertrophic rhinitis: a prospective comparative study

Furculița D., Maniuc M., Danilov L., Ababii P.

Nicolae Testemițanu State University of Medicine and Pharmacy, Center for Personalized Medicine, Otorhinolaryngology Laboratory, Chisinau, Republic of Moldova

Abstract

Chronic hypertrophic rhinitis in children is a common pathology associated with inferior turbinate hypertrophy, persistent nasal obstruction, and impaired quality of life. Surgical interventions to reduce turbinate volume, such as diode laser and bipolar cautery, are widely used, but postoperative inflammation and mucosal regeneration can be prolonged. Autologous cell therapy represents a promising regenerative approach to accelerate tissue healing.
Objective – to evaluate the effectiveness of postoperative autologous mononuclear cell therapy in the rehabilitation of children with chronic hypertrophic rhinitis following surgical treatment.
Methods. The study was prospective, interventional, and comparative, conducted on a group of 40 children aged 7 to 17 years diagnosed with chronic hypertrophic rhinitis. Patients were divided into four groups (n = 10/group): diode laser (DL), diode laser + cell therapy (DL+CT), bipolar cautery (BC), and bipolar cautery + cell therapy (BC+CT). Cell therapy consisted of the postoperative local administration of a suspension of autologous mononuclear cells obtained from peripheral blood. The evaluation included the NOSE symptom score, rhinomanometry, acoustic rhinometry and endoscopic examination. The follow-up period was 24 months.
Results. All groups showed postoperative clinical improvement. The cell therapy groups demonstrated a significantly faster and more stable reduction in symptoms, with a decrease in the NOSE score to 14 ± 4 in the DL+CT group at 24 months, compared to 30 ± 6 in DL and 36 ± 7 in BC. Nasal resistance decreased more sharply in the cell therapy groups, and the incidence of persistent edema, crusting and relapses was lower.
Conclusions. Autologous cell therapy applied postoperatively accelerates the regeneration of the nasal mucosa and improves functional outcomes in children with chronic hypertrophic rhinitis, with maximum efficiency in combination with diode laser.

Keywords: chronic hypertrophic rhinitis; cell therapy; nasal turbinates; diode laser; bipolar cauterization; pediatrics

Full text PDF

References

1. Abdullah, B., & Singh, S. (2021). Surgical interventions for inferior turbinate hypertrophy: a comprehensive review of current techniques and technologies. International journal of environmental research and public health, 18(7), 3441. Available at: https://pubmed.ncbi.nlm.nih.gov/33810309/ https://doi.org/10.3390/ijerph18073441 PMid:33810309 PMCid:PMC8038107

2. Abolghasemi, R., Davoudi-Monfared, E., & Mashayekhi, J. (2025). Cell therapy clinical trials for otorhinolaryngology disease treatment: a systematic review. The Egyptian Journal of Otolaryngology, 41(1), 217. Available at: https://link.springer.com/article/10.1186/s43163-025-00968-3 https://doi.org/10.1186/s43163-025-00968-3

3. Brennan, L. C., O’Sullivan, A., & MacLoughlin, R. (2021). Cellular therapy for the treatment of paediatric respiratory disease. International Journal of Molecular Sciences, 22(16), 8906. Available at: https://pubmed.ncbi.nlm.nih.gov/34445609/ https://doi.org/10.3390/ijms22168906 PMid:34445609 PMCid:PMC8396271

4. Calvo-Henriquez, C., Tucciarone, M., Lechien, J. R., Maniaci, A., Graham, E., Maza-Solano, J., … & Martin-Martin, C. (2023). Turbinate surgery in pediatric patients: A worldwide survey. Acta Otorrinolaringológica Española, 74(2), 93-100. Available at: https://pubmed.ncbi.nlm.nih.gov/37005043/ https://doi.org/10.1016/j.otorri.2022.02.004

5. Ciprandi, G., & Tosca, M. A. (2021). Turbinate hypertrophy, allergic rhinitis, and otitis media. Current allergy and asthma reports, 21(7), 40. Available at: https://pubmed.ncbi.nlm.nih.gov/34390424/ https://doi.org/10.1007/s11882-021-01016-9 PMid:34390424

6. Furculița, D. (2023). Contemporary management of hypertrophy of the inferior nasal turbinates. Publishing House “Baltija Publishing”. Available at: https://repository.usmf.md/handle/20.500.12710/26571 https://doi.org/10.30525/978-9934-26-310-1-4

7. Furculița, D. (2023). The role of rhinomanometry in evaluating the effectiveness of laser surgical treatment in children with chronic hypertrophic rhinitis. Child’s Health, 166-170. Available at: https://childshealth-journal.com/index.php/journal/article/view/1580 https://doi.org/10.22141/2224-0551.18.3.2023.1580

8. Gelardi, M., Giancaspro, R., Bocciolini, C., Salerni, L., & Cassano, M. (2022). Turbinate surgery: Which rhinitis are most at risk. Acta Bio Medica: Atenei Parmensis, 93(4), e2022249. Available at: https://pubmed.ncbi.nlm.nih.gov/36043980/

9. Hwang, S. H. (2024). Human nasal turbinate-derived stem cells for tissue engineering and regenerative medicine. Journal of Rhinology, 31(3), 133-137. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11685919/ https://doi.org/10.18787/jr.2024.00030 PMid:39744452 PMCid:PMC11685919

10. Kang, Y. J., Park, D. B., Jang, D. W., Lim, M. H., Lee, J. Y., Yoo, S. Y., … & Kim, D. H. (2025). Optimizing Human Nasal Turbinate Stem Cell Dosage for the Effective Treatment of Empty Nose Syndrome. Journal of Rhinology, 32(3), 175-183. Available at: https://pubmed.ncbi.nlm.nih.gov/41365488/ https://doi.org/10.18787/jr.2025.00021 PMid:41365488 PMCid:PMC12689091

11. Karamatzanis, I., Kosmidou, P., Ntarladima, V., Catalli, B., Kosmidou, A., Filippou, D., & Georgalas, C. (2022). Inferior turbinate hypertrophy: a comparison of surgical techniques. Cureus, 14(12). Available at: https://pubmed.ncbi.nlm.nih.gov/36654608/ https://doi.org/10.7759/cureus.32579 PMid:36654608 PMCid:PMC9840750

12. Kim, D. H., Kim, S. H., Park, S. H., Kwon, M. Y., Lim, C. Y., Park, S. H., … & Kim, S. W. (2023). Characteristics of human nasal turbinate stem cells under hypoxic conditions. Cells, 12(19), 2360. Available at: https://pubmed.ncbi.nlm.nih.gov/37830573/ https://doi.org/10.3390/cells12192360 PMid:37830573 PMCid:PMC10571865

13. Komshian, S. R., Cohen, M. B., Brook, C., & Levi, J. R. (2019). Inferior turbinate hypertrophy: a review of the evolution of management in children. American journal of rhinology & allergy, 33(2), 212-219. Available at: https://pubmed.ncbi.nlm.nih.gov/30554518/ https://doi.org/10.1177/1945892418815351 PMid:30554518

14. Maniaci, A., Calvo‐Henriquez, C., Cammaroto, G., Garcia‐Magan, C., Garcia‐Paz, V., Iannella, G., … & Saibene, A. M. (2024). Pediatric Inferior Turbinate Hypertrophy: Diagnosis and Management. A YO‐IFOS Consensus Statement. The Laryngoscope, 134(3), 1437-1444. Available at: https://pubmed.ncbi.nlm.nih.gov/37497872/ https://doi.org/10.1002/lary.30907 PMid:37497872

15. McPhail, M. J., Janus, J. R., & Lott, D. G. (2020). Advances in regenerative medicine for otolaryngology/head and neck surgery. Bmj, 369. Available at: https://pubmed.ncbi.nlm.nih.gov/32349978/ https://doi.org/10.1136/bmj.m718 PMid:32349978

16. Oh, S. Y., Kim, H. Y., Jung, S. Y., & Kim, H. S. (2024). Tissue engineering and regenerative medicine in the field of otorhinolaryngology. Tissue Engineering and Regenerative Medicine, 21(7), 969-984. Available at: https://pubmed.ncbi.nlm.nih.gov/39017827/ https://doi.org/10.1007/s13770-024-00661-1 PMid:39017827 PMCid:PMC11416456

17. Park, D. B., Lee, J. Y., Kim, S. W., & Kim, D. H. (2024). Tissue specific stem cell therapy for airway regeneration. Cell Proliferation, 57(10), e13662. Available at: https://pubmed.ncbi.nlm.nih.gov/38803033/ https://doi.org/10.1111/cpr.13662 PMid:38803033 PMCid:PMC11471432

18. Scholes, M. A., & Ramakrishnan, V. R. (2022). ENT secrets E-book: ENT secrets E-book. Elsevier Health Sciences. Available at: https://evolve.elsevier.com/cs/product/9780323733601?role = student

19. Shukla, R. H., Nemade, S. V., & Shinde, K. J. (2020). Comparison of visual analogue scale (VAS) and the Nasal Obstruction Symptom Evaluation (NOSE) score in evaluation of post septoplasty patients. World journal of otorhinolaryngology-head and neck surgery, 6(01), 53-58. Available at: https://mednexus.org/doi/full/10.1016/j.wjorl.2019.06.002 https://doi.org/10.1016/j.wjorl.2019.06.002 PMid:32426704 PMCid:PMC7221206

20. Wormald, J. C. R., Fishman, J. M., Juniat, S., Tolley, N., & Birchall, M. A. (2015). Regenerative medicine in otorhinolaryngology. The Journal of Laryngology & Otology, 129(8), 732-739. Available at: https://pubmed.ncbi.nlm.nih.gov/26104952/ https://doi.org/10.1017/S0022215115001577 PMid:26104952

21. Yan, C. H., & Hwang, P. H. (2018). Surgical management of nonallergic rhinitis. Otolaryngologic Clinics of North America, 51(5), 945-955. Available at: https://pubmed.ncbi.nlm.nih.gov/29937065/ https://doi.org/10.1016/j.otc.2018.05.010 PMid:29937065

22. Zhang, K., Pipaliya, R. M., Miglani, A., Nguyen, S. A., & Schlosser, R. J. (2023). Systematic review of surgical interventions for inferior turbinate hypertrophy. American journal of rhinology & allergy, 37(1), 110-122. Available at: https://pubmed.ncbi.nlm.nih.gov/36315624/ https://doi.org/10.1177/19458924221134555 PMid:36315624

How to cite

Furculița D, Maniuc M, Danilov L, Ababii P. Postoperative autologous peripheral blood mononuclear cell therapy in the rehabilitation of children with chronic hypertrophic rhinitis: a prospective comparative study. Cell Organ Transpl. 2026; 14(1):e2026141188. doi: https://doi.org/10.22494/cot.v14-1.188

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.